Achim Moeller

USPTO Granted Patents = 30 (Patent Applications = 10)

CIPO Patents = 6 (Patent Applications = 10)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 314(Granted Patents)

Location History:

Limburgerhof, DE (1990 - 1993)
Winchester, MA (US) (1994)
Grundstadt, DE (2009)
Grünstadt, DE (2010)
Wiesbaden, DE (2015 - 2016)
Gruenstadt, DE (2011 - 2018)
Grunstadt, DE (2012 - 2019)
Ludwigshafen, DE (2012 - 2020)
Dresden, DE (2018 - 2020)

Company Filing History:

13 out of 167

Abbvie Deutschland Gmbh and Co Kg

Basf Aktiengesellschaft

patents

5. 3 out of 4,179

Abbott Laboratories Corporation

patents

6. 3 out of 5

Wood Innovations Ltd.

patents

7. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1990-2025

Loading Chart...

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486664 - Core layer having wood elements, in particular wood elements having a corrugated structure (2025-12-02),

2. 10814936 - Core layer having wood elements, in particular wood elements having a corrugated structure (2020-10-27),

3. 10556914 - Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use (2020-02-11),

4. 10464976 - Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof (2019-11-05),

5. 10245749 - Method and apparatus for the fabrication of an endless band from a fiber material block, endless band and fiber material block (2019-04-02),

6. 10155770 - Substituted pyrazolopyrimidines and method of use (2018-12-18),

7. 10053191 - Core layer having wood elements, in particular wood elements having a corrugated structure (2018-08-21),

8. 10040852 - Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof (2018-08-07),

9. 9828381 - Substituted pyrazolopyrimidines and method of use (2017-11-28),

10. 9567325 - Carboxamide compounds and their use as calpain inhibitors (2017-02-14),

11. 9527811 - Carboxamide compounds and their use as calpain inhibitors (2016-12-27),

12. 9255146 - Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof (2016-02-09),

13. 9176150 - Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof (2015-11-03),

14. 9150553 - Carboxamide compounds and their use as calpain inhibitors (2015-10-06),

15. 9139557 - Carboxamide compounds and their use as calpain inhibitors (2015-09-22),

Title: Exploring the Inventive World of Achim Moeller

Introduction:

Achim Moeller, a prolific inventor hailing from Ludwigshafen, DE, has left a significant mark in the world of patents with an impressive count of 26 to his name. His groundbreaking innovations have focused on areas such as pharmaceuticals and neurology, revolutionizing the field with his novel solutions.

Latest Patents:

Moeller's latest patents encompass a wide array of advancements in the realm of pharmaceuticals. One notable invention includes "Substituted isoxazolopyridazinones and isothiazolopyridazinones," targeting conditions modulated by the GABA-B receptor. Additionally, his work on "Amyloid β(1-42) oligomers" showcases his expertise in neurology, presenting new methods for diagnosis and therapy in this complex area.

Career Highlights:

Throughout his career, Moeller has showcased a strong dedication to innovation. Having worked at renowned companies like AbbVie Deutschland GmbH & Co. KG and AbbVie Inc., he has honed his skills and expertise in the pharmaceutical industry. His contributions have not only propelled his own career but have also significantly impacted the field as a whole.

Collaborations:

Moeller's collaborative spirit is evident through his partnerships with esteemed professionals in the field. Colleagues such as Helmut Mack and Andreas Kling have worked alongside him, contributing to the success of various projects and further solidifying Moeller's reputation as a respected innovator.

Conclusion:

In conclusion, Achim Moeller stands as a pioneering figure in the world of inventions and patents. His relentless pursuit of innovation, coupled with his strategic collaborations and career milestones, cements his legacy as a trailblazer in the pharmaceutical and neurology sectors. His journey exemplifies the power of inventive thinking in driving meaningful progress and advancements in crucial industries.

This text is generated by artificial intelligence and may not be accurate.